DelMar Pharmaceuticals Inc (OTCQX US:DMPI)

Data as of 10:20am ET
 +0.01 / +1.45%
Today’s Change
Today|||52-Week Range

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line-5.6K-33.1K-18.9K-8.3M
Total Other Cash Flow0.
Funds From Operations-5.6K-33.1K-18.9K-4.5M
Funds From/For Other Operating Expenses-652.005.7K-7.5K983.6K
Net Cash Flow - Operating Activities-4.9K-38.8K-11.4K-5.5M
InvestingNet Cash Flow Investing0.
FinancingShort Term Borrowings----------
Long Term Borrowings----------
Long Term Debt Reduction----------
Net Proceeds Stock Sale----------
Common Preferred Redeemed----------
Common Dividends----------
Cash Dividends Paid - Total0.
Other Sources - Financing----------
Other Uses - Financing----------
Net Cash Flow - Financing49.5K0.007.5K9.6M
Exchange RateEffect of Exchange Rate on Cash-9.00-
Net Change In Cash44.6K-38.8K-3.9K4.1M

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.